More than 500 of GSK’s suppliers to its manufacturing and R&D divisions globally have been actively asked to share and take forward practical ideas to improve energy efficiency and reduce environmental impacts through GSK’s Supplier Exchange. GSK, which often utilises a collaboration approach across all parts of its business, has set up the GSK Supplier Exchange to help reduce its carbon footprint across its value chain by 25% by 2020.
Next week, world leaders will launch a new round of goals, targets and indicators to pick up where the Millennium Development Goals left off. In the new issue of Novo Nordisk’s sustainability magazine – TBL Quarterly – the company shows how improving the prevention and treatment of type 2 diabetes plays a key role in achieving many of the 17 new Sustainable Development Goals (SDGs).